Myles Hume, Author at Insight - Page 3 of 119

Friday, January 23, 2026

No Results

View All Results

No Results

View All Results

Home Author

Myles Hume

ZEISS MCI Patents

Company updates & acquisitions

ZEISS secures Brighten Optix contact lens acquisition

PFF believes it can instigate the most change through the HSU, which exists to solely represent employees in industrial matters. Image: leungchopan/stock.adobe.com.

News

Phoropter Free Fridays – new movement plans to unionise Australian optometry

IPL being performed in a Specsavers practice. Image: Specsavers.

Feature

Will Specsavers adopt IPL? The early results are in

Results also indicated 84% of ZEISS MyoCare lens wearers adapted to the lenses in less than three days. Image: ZEISS.

News

Latest data confirms ZEISS MyoCare slows myopia progression

OA has raised concerns about an imbalance between workforce supply and demand, while acknowledging the complex reality of maldistribution. Image: lamingo Images.

News

Key findings from new Optometry Australia-backed workforce projections report

Optometrists keen to do more in their careers are urged to consider working in independent practice. Image: Viacheslav Yakobchuk/stock.adobe.com.

News

Complaints against Australian optometrists hit a five-year high

eye injection incentive

News

Up to ‘$150 per bulk billed patient’ – more details on proposed eye injection incentive

The new Pentacam Cornea OCT system and Myopia Master are popular in the OCULUS product portfolio. Images: OCULUS.

Local

Grills-founded Ophthalmix secures OCULUS distribution for Australia

The company's 2 mg sozinibercept is intravitreally administered with standard-of-care anti-VEGF drugs. Image: Numstocker/Shutterstock.com.

News

Opthea discontinuing nAMD trials

Opticare's Sydney Open Day in January was an opportunity for practice decision makers to get hands-on with Opticare products. Image: Opticare.

Local

Opticare taking popular Open Days to Brisbane and Perth

Page 3 of 119 Prev 1 2 3 4 … 119 Next

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

Popular Topics

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results

View All Results

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited